Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: BioMed Research International 2014 (2014).
- Keyword
-
-
Krebs
Onkologie
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2015
- Contributor
-
Hein, Alexander
Bayer, Christian M.
Schrauder, Michael G.
Häberle, Lothar
Heusinger, Katharina
Strick, Reiner
Ruebner, Matthias
Lux, Michael P.
Renner, Stefan P
Schulz-Wendtland, Rüdiger
Ekici, Arif B.
Hartmann, Arndt
Beckmann, Matthias W.
Fasching, Peter A.
- URN
-
urn:nbn:de:bvb:29-opus4-57772
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:53 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hein, Alexander
- Bayer, Christian M.
- Schrauder, Michael G.
- Häberle, Lothar
- Heusinger, Katharina
- Strick, Reiner
- Ruebner, Matthias
- Lux, Michael P.
- Renner, Stefan P
- Schulz-Wendtland, Rüdiger
- Ekici, Arif B.
- Hartmann, Arndt
- Beckmann, Matthias W.
- Fasching, Peter A.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2015
Other Objects (12)
Invasive Breast Cancer: Recognition of Molecular Subtypes
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
Untersuchung der Invasivität von primären Endometriosezellen
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Teilnahmerate an einer chemopräventiven Behandlung in der IBIS-II-Studie : eine prospektive Kohortenstudie im Rahmen des Mammographiescreenings
Methoden der Statistik zur Analyse von Single Nucleotide Polymorphism (SNP) anhand der Auswertung von Genotypdaten aus einer neoadjuvanten Chemotherapiestudie
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
Invasive Breast Cancer: Recognition of Molecular Subtypes
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
Untersuchung der Invasivität von primären Endometriosezellen
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Teilnahmerate an einer chemopräventiven Behandlung in der IBIS-II-Studie : eine prospektive Kohortenstudie im Rahmen des Mammographiescreenings
Methoden der Statistik zur Analyse von Single Nucleotide Polymorphism (SNP) anhand der Auswertung von Genotypdaten aus einer neoadjuvanten Chemotherapiestudie
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
Invasive Breast Cancer: Recognition of Molecular Subtypes
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
Untersuchung der Invasivität von primären Endometriosezellen
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Teilnahmerate an einer chemopräventiven Behandlung in der IBIS-II-Studie : eine prospektive Kohortenstudie im Rahmen des Mammographiescreenings
Methoden der Statistik zur Analyse von Single Nucleotide Polymorphism (SNP) anhand der Auswertung von Genotypdaten aus einer neoadjuvanten Chemotherapiestudie